Callan Family Office’s Sherwin-Williams SHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
5,748
-1,609
-22% -$514K 0.04% 394
2026
Q1
$2.36M Sell
7,357
-2,793
-28% -$961K 0.05% 312
2025
Q4
$3.29M Buy
10,150
+2,257
+29% +$755K 0.07% 253
2025
Q3
$2.73M Sell
7,893
-1,249
-14% -$440K 0.09% 230
2025
Q2
$3.14M Buy
9,142
+7,404
+426% +$2.57M 0.1% 214
2025
Q1
$607K Sell
1,738
-4,343
-71% -$1.52M 0.05% 286
2024
Q4
$2.07M Buy
6,081
+3,384
+125% +$1.26M 0.13% 144
2024
Q3
$1.03M Buy
+2,697
New +$941K 0.17% 64

Other funds holding SHW

Callan Family Office's SHW Position: Q2 2026 in Review

Callan Family Office reduced its Sherwin-Williams (SHW) stake by 22% in Q2 2026, selling an estimated $514K and leaving 5,748 shares worth $1.98M. The position accounts for 0.04% of the portfolio, ranked #394.

Callan Family Office first reported a position in SHW in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.29M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold SHW as of Q2 2026.

  • Callan Family Office held 5,748 shares of Sherwin-Williams worth $1.98M as of Q2 2026.
  • Callan Family Office sold 1,609 Sherwin-Williams shares in Q2 2026, an estimated $514K.
  • Sherwin-Williams made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #394 holding.
  • Callan Family Office first reported a position in Sherwin-Williams in Q3 2024 and has held it in 8 quarters since.
  • Callan Family Office's Sherwin-Williams position peaked at $3.29M in Q4 2025.
  • 1,747 funds tracked by Wall St. Rank held Sherwin-Williams as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.